市场调查报告书
商品编码
1517758
金纳米棒市场 - 全球产业规模、份额、趋势、机会和预测,按类型、最终用户、地区和竞争细分,2019-2029FGold Nanorods Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By End User, By Region and Competition, 2019-2029F |
2023 年全球金奈米棒市场价值为 1.1235 亿美元,预计在预测期内将稳定成长,到 2029 年复合年增长率为 16.45%。直径在1 到100 奈米之间,长度通常是直径的几倍。这些奈米棒因其尺寸和形状而具有独特的光学特性,特别是在电磁波谱的可见光和近红外线区域。它们是使用精确的化学技术合成的,以获得具有影响其独特特性的特定尺寸的细长形状。值得注意的是,它们在可见光到近红外线范围内表现出强烈的表面等离子共振(SPR),这使得它们在成像、感测和治疗等光学应用中具有重要价值。表面修饰允许对金奈米棒进行定制,以增强生物医学领域的生物相容性和靶向递送,确保在不同生物环境中的稳定性。它们的化学稳定性和抗氧化性进一步增强了实际应用中的可靠性。金奈米棒在癌症治疗、诊断和成像等生物医学用途中已被广泛研究,因为它们能够吸收和散射近红外线范围内的光,非常适合光热疗法等技术。在生物感测平台中,它们的高表面积与体积比和易于生物分子功能化使得能够灵敏地检测生物标记和病原体。在催化方面,它们独特的形状和表面特性有助于提高氧化和氢化过程等反应中的催化活性。奈米製造技术和表面化学的进步继续扩大其潜在应用。
市场概况 | |
---|---|
预测期 | 2025-2029 |
2023 年市场规模 | 11235万美元 |
2029 年市场规模 | 2.773亿美元 |
2024-2029 年复合年增长率 | 16.45% |
成长最快的细分市场 | 电子与半导体 |
最大的市场 | 北美洲 |
儘管有关安全和环境影响的监管考虑带来了挑战,但金奈米棒市场仍然很小,但在各个行业都显示出广阔的成长前景。持续的研究、技术进步和战略合作伙伴关係将是在可预见的未来推动市场扩张的关键。
增加生物医学应用的研发
医疗保健支出
生产成本高
技术限制
电子领域的新兴应用
类型洞察
最终使用者见解
区域洞察
Global Gold Nanorods Market was valued at USD 112.35 Million in 2023 and is anticipated to project steady growth in the forecast period with a CAGR of 16.45% through 2029. Gold nanorods are tiny structures composed of gold atoms arranged in a rod-like form, typically measuring between 1 and 100 nanometers in diameter, with lengths often several times their diameter. These nanorods possess unique optical characteristics attributable to their size and shape, particularly in the visible and near-infrared regions of the electromagnetic spectrum. They are synthesized using precise chemical techniques to achieve elongated shapes with specific dimensions that influence their distinct properties. Notably, they exhibit strong surface plasmon resonance (SPR) within the visible to near-infrared range, making them valuable for applications in optics such as imaging, sensing, and therapeutic treatments. Surface modifications allow gold nanorods to be tailored for enhanced biocompatibility and targeted delivery in biomedical fields, ensuring stability in diverse biological environments. Their chemical stability and resistance to oxidation further enhance reliability in practical applications. Gold nanorods are extensively researched for biomedical uses such as cancer therapy, diagnostics, and imaging, owing to their ability to absorb and scatter light in the near-infrared range, ideal for techniques like photothermal therapy. In biosensing platforms, their high surface area-to-volume ratio and ease of functionalization with biomolecules enable sensitive detection of biomarkers and pathogens. In catalysis, their unique shape and surface properties contribute to heightened catalytic activity in reactions including oxidation and hydrogenation processes. Advances in nanofabrication techniques and surface chemistry continue to expand their potential applications.
Market Overview | |
---|---|
Forecast Period | 2025-2029 |
Market Size 2023 | USD 112.35 Million |
Market Size 2029 | USD 277.30 Million |
CAGR 2024-2029 | 16.45% |
Fastest Growing Segment | Electronics & Semiconductor |
Largest Market | North America |
While regulatory considerations regarding safety and environmental impact pose challenges, the market for gold nanorods remains niche but shows promising growth prospects across various industries. Continued research, technological advancements, and strategic partnerships will be pivotal in driving market expansion in the foreseeable future.
Key Market Drivers
Increasing R&D for biomedical applications
Increasing investments in research and development (R&D) aimed at biomedical applications are pivotal in driving the growth of the global market for gold nanorods. These investments are paving the way for innovative therapies, enhanced diagnostic tools, and novel biomedical solutions to address critical healthcare challenges. Gold nanorods possess unique properties, such as their ability to convert light into heat (utilized in photothermal therapy), which researchers are leveraging to develop advanced cancer treatment methods that selectively target cancer cells while minimizing damage to healthy tissue. Researchers at the Technical University of Munich (TUM) have developed a groundbreaking microrobot, named TACSI (Thermally Activated Cell-Signal Imaging), which they claim is the first of its kind. This newly designed micro-robotic system, featured in the journal Advanced Healthcare Materials, is circular and remarkably thin-about half the diameter of a human hair. Constructed from gold nanorods and fluorescent luminous dye enclosed in a biomaterial derived from algae, these microbots are currently utilized for in vitro applications. The developers envision potential innovative treatments, including targeted drug delivery to individual cells, facilitated by this microbot technology. Additionally, gold nanorods can be modified to effectively deliver drugs or therapeutic agents to specific sites within the body. In 2024, researchers published a study in the journal Nature presenting a synergistic method that combines chemo-photothermal treatment using gold nanorods (AuNRs) supported on thiol-functionalized mesoporous silica. This approach shows potential for significantly enhancing lung cancer therapy. By integrating gold nanorods, thiol-functionalized mesoporous silica, and drug release responsive to both pH and near-infrared (NIR) light, the research offers a comprehensive and effective treatment strategy to improve outcomes in lung cancer therapy. Future advancements built upon this approach hold promise for addressing cancer challenges and revolutionizing patient care. Researchers are actively exploring various surface modifications and targeting strategies to improve drug delivery efficiency and reduce potential side effects.
Gold nanorods exhibit strong optical properties, particularly in the near-infrared (NIR) range, making them valuable for imaging applications. They enhance contrast in imaging techniques like photoacoustic imaging and optical coherence tomography, improving tissue visualization and enabling early disease detection. Significant R&D efforts are dedicated to ensuring the biocompatibility and safety of gold nanorods for biomedical use. This includes studying their interactions with biological systems, assessing potential toxicity risks, and developing methods to enhance their stability and compatibility with living tissues.
In May 2024, ArgusEye, a company specializing in advanced sensor technology for biopharmaceutical manufacturing, announced the successful completion of a new funding round, raising approximately 2.8 million Euro. Voima Ventures led the round, with co-leadership from Eir Ventures, who continued their support from a previous Seed investment. This funding injection accelerates ArgusEye's efforts to revolutionize the development and production of new biomedicines. R&D initiatives are focused on navigating regulatory pathways to secure approval and commercialization of biomedical products based on gold nanorods. These comprehensive efforts underscore the critical role of ongoing R&D in advancing the application and market expansion of gold nanorods across various biomedical sectors.
Healthcare expenditure
Healthcare expenditure plays a crucial role in driving the global nanorods market by promoting innovation, advancing technology, and addressing healthcare challenges through nanotechnology applications in diagnostics, imaging, drug delivery, and therapeutics. Increased global healthcare spending stimulates demand for advanced medical technologies and treatments. Nanorods, particularly gold nanorods, are leading innovations in medical diagnostics, imaging, and therapy due to their distinctive properties.
According to a report by the Institute for Health Metrics and Evaluation, healthcare spending per person in the United States averaged $13,000 in 2021 and is projected to rise to $20,200 by 2050. This upward trend in healthcare expenditure underscores the increasing focus on managing chronic illnesses like cancer, cardiovascular diseases, and neurological disorders. Nanorods are being investigated for their potential in targeted drug delivery, enhancing imaging capabilities, and therapeutic applications, aligning with the need for effective chronic disease management.
Healthcare expenditure also promotes the development and adoption of precision medicine strategies, emphasizing personalized treatment approaches. Nanorods enable precise targeting of therapies and diagnostics at molecular and cellular levels, thereby supporting advancements in precision medicine initiatives.
The global aging population imposes greater demands on healthcare systems, leading to increased investments in healthcare services and technologies. Nanorods present promising solutions for age-related diseases and conditions, further propelling their adoption and market expansion.
Key Market Challenges
High Cost of Production
The high production costs pose a significant challenge for the global gold nanorods market. These costs stem from the intricate synthesis processes and the expensive raw materials necessary for their production. Consequently, gold nanorods may not be affordable for applications requiring large quantities or widespread use. Moreover, the competitiveness of gold nanorods is hindered by their high production costs compared to alternative materials or technologies offering similar functionalities at lower prices. This challenge restricts their market penetration across various industries.
Scaling production from laboratory to commercial levels involves substantial investments in equipment, facilities, and process optimization. The initial high investment required for scaling up can particularly deter smaller companies or startups from entering the market. Furthermore, the substantial resources needed for production can divert funds away from research and development efforts focused on exploring new applications or enhancing the performance of gold nanorods. As a result, innovation may be slowed, limiting the emergence of new market opportunities.
Technological Limitations
The synthesis of gold nanorods involves intricate processes that demand precise control over factors such as temperature, pH, and reaction times. Variations in these parameters can lead to inconsistencies in nanorod size, shape, and properties during production. Ensuring uniform size and shape distribution of gold nanorods is crucial for their performance in applications like biomedical diagnostics and therapeutic delivery. Technical challenges in maintaining this consistency can impact the reproducibility and reliability of nanorods. For example, deviations in seed-mediated growth methods may result in dimensional variations that affect their optical properties and effectiveness in targeted therapies.
Gold nanorods are susceptible to environmental influences such as pH shifts, temperature fluctuations, and light exposure, necessitating measures to ensure their stability across diverse conditions. This stability is vital for their practical application in various fields.
Functionalizing the surface of gold nanorods with molecules or biomolecules is essential for specific biomedical uses. However, challenges arise in achieving effective and stable functionalization while preserving the inherent properties of the nanorods. For instance, attaching targeting ligands to nanorod surfaces for precise cancer cell targeting requires robust chemical bonding techniques that do not compromise their optical or therapeutic qualities.
Integrating gold nanorods into practical devices or systems often involves addressing compatibility issues with existing technologies and materials. Technical considerations include ensuring the stability of nanorods within device components and optimizing their interaction with biological systems. For example, incorporating nanorods into biosensors requires overcoming compatibility challenges with sensor substrates and refining signal detection mechanisms.
Key Market Trends
Emerging applications in electronics
Gold nanorods demonstrate strong plasmonic properties, which are valuable in optical sensors and photodetectors. For example, researchers have devised highly sensitive optical sensors using gold nanorods to detect specific molecules or gases with precision and accuracy. These sensors capitalize on the nanorods' ability to interact with light at the nanoscale, enabling precise detection and analysis in fields such as environmental monitoring and biomedical diagnostics.
Gold nanorods are also being investigated for their potential in transparent conductive films utilized in touchscreens, displays, and solar cells. Their conductivity and optical transparency render them viable alternatives to conventional materials like indium tin oxide (ITO). By incorporating gold nanorods into these films, manufacturers can enhance conductivity while preserving high optical transparency, essential for applications requiring both functionalities. Researchers from China have developed a flexible infrared metamaterial absorber using gold nanorods dispersed in liquid crystal (LC), positioned on a gold film. They conducted a theoretical analysis of its total absorption capabilities, publishing their findings in the journal Scientific Reports in 2024. This metamaterial absorber exhibits key features such as flexibility, omnidirectional absorption, broadband capability, and tunability, indicating its potential applications in advanced smart metamaterial devices.
Gold nanorods are compatible with manufacturing processes for flexible and printed electronics, facilitating integration into wearable devices, smart textiles, and flexible displays. Their flexibility and robustness make them ideal for applications demanding conformal and bendable electronics. Manufacturers are actively exploring scalable techniques to print or deposit gold nanorods onto flexible substrates, expanding their utilization in consumer electronics and IoT devices.
In a recent publication in National Science Review, researchers detailed a study on dynamically and reversibly controlling surface plasmons through the transport of hot carriers. This research merges the rapid response of metal nanoplasmons with the optoelectronic modulation capabilities of semiconductors. By optically exciting hot electrons, the study manipulates the charge density within gold and adjusts the conductivity of nanogaps, enabling ultrafast and reversible switching of plasmon resonances. This advancement represents a significant prototype for optoelectronic switches in nanophotonic chips. There is a growing focus on research and development initiatives aimed at refining the synthesis, functionalization, and integration of gold nanorods into electronic devices. This encompasses exploring novel fabrication methods, enhancing material properties, and establishing scalable manufacturing processes suitable for widespread commercial applications.
Segmental Insights
Type Insights
Based on Type, the LSPR below 900nm emerged as the dominant segment in the global market for Gold Nanorods in 2023. Gold nanorods with LSPR below 900nm excel in biomedical applications, particularly in cancer treatment through photothermal therapy. Their optical properties include a strong absorption peak in the near-infrared (NIR) range (typically 700-900nm), aligning well with tissue transparency, which enhances their effectiveness. These nanorods also play essential roles in advanced imaging technologies such as photoacoustic imaging and optical coherence tomography. Their flexibility for functionalization with targeting molecules or drugs facilitates precise and targeted therapy delivery. Extensive research and development efforts continue to optimize these nanorods for biomedical use, advancing synthesis techniques, surface modifications, and understanding of their biological interactions. These ongoing innovations solidify their dominant position in the market, driven by their unique optical capabilities, therapeutic efficacy, versatility across medical applications, and continuous technological advancements.
End User Insights
Based on end user, the Healthcare & Pharmaceuticals segment emerged as the dominant in the global market for Gold Nanorods in 2023. The unique optical, thermal, and biocompatible characteristics of gold nanorods make them versatile tools for advancing diagnostics, therapies, and drug delivery systems in healthcare. Their potential to enhance treatment outcomes and patient care is a key driver of their prominent role in these crucial sectors. Gold nanorods can be customized with various molecules, such as drugs or targeting ligands, enabling precise and targeted delivery to specific cells or tissues. Their biocompatibility and ability to permeate cellular membranes position them as promising vehicles for therapeutic agents. This approach to targeted drug delivery reduces systemic toxicity and amplifies treatment effectiveness. Ongoing research and development efforts focus on refining the synthesis, functionalization, and biomedical applications of gold nanorods. This includes enhancing their stability, augmenting targeting capabilities, and exploring novel therapeutic applications. Continuous innovation in this field propels the expansion of their utility across healthcare and pharmaceutical industries.
Regional Insights
Based on Region, North America emerged as the dominant region in the Global Gold Nanorods Market in 2023. This can be attributed to advanced technology expertise, robust healthcare infrastructure, supportive regulatory frameworks, strong market demand, and extensive research and development efforts. North America serves as a center for technological innovation and research, particularly in biotechnology, healthcare, and nanotechnology. This environment facilitates significant progress in synthesizing, applying, and commercializing Gold Nanorods across various industries. The region benefits from advanced healthcare infrastructure and a robust pharmaceutical sector, where Gold Nanorods play a crucial role in biomedical applications such as drug delivery systems, diagnostics, and therapeutic treatments.
American Elements
CD Bioparticles, Inc
Cytodiagnostics Inc.
Strem Chemicals, Inc.
Merck KGaA
Nanoshel LLC
NanoComposix
Sona Nanotech Inc.
Nanowerk LLC
Beijing DK Nano Technology Co. Ltd
In this report, the Global Gold Nanorods Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies presents in the Global Gold Nanorods Market.
Global Gold Nanorods Market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Detailed analysis and profiling of additional market players (up to five).